109 related articles for article (PubMed ID: 7155241)
1. Behaviour of arterial pressure in different stages of polycystic kidney disease.
Calabrese G; Vagelli G; Cristofano C; Barsotti G
Nephron; 1982; 32(3):207-8. PubMed ID: 7155241
[No Abstract] [Full Text] [Related]
2. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
[TBL] [Abstract][Full Text] [Related]
3. [Creatinine levels in polycystic kidney disease complicated by arterial hypertension. Role of blood pressure control].
Abdelrhamane M; Jeunemaître X; Plouin PF; Chatellier G; Tugayé A
Presse Med; 1990 Nov; 19(39):1801-4. PubMed ID: 2148004
[TBL] [Abstract][Full Text] [Related]
4. Different effect of IgA nephropathy and polycystic kidney disease on arterial stiffness.
Késoi I; Sági B; Tóth OI; Vas T; Fazekas A; Kovács T; Pintér T; Wittmann I; Nagy J
Kidney Blood Press Res; 2011; 34(3):158-66. PubMed ID: 21474963
[TBL] [Abstract][Full Text] [Related]
5. [Acquired cystic disease and progressive renal deterioration: correlation with underlying nephropathy and with genetic markers].
Di Maio G; Lamperi D; Icardi A; Derchi L; Caimo A; Lamperi S
Minerva Urol Nefrol; 1987; 39(3):305-10. PubMed ID: 3481476
[No Abstract] [Full Text] [Related]
6. The Verona experience on the effect of diet on progression of renal failure.
Oldrizzi L; Rugiu C; Maschio G
Kidney Int Suppl; 1989 Nov; 27():S103-5. PubMed ID: 2636642
[No Abstract] [Full Text] [Related]
7. [Behavior of arterial pressure in bilateral polycystic kidney].
Zucchelli P; Sasdelli M; Fusaroli M; Chiarini C; Fabbri L
Minerva Nefrol; 1972; 19(2):117-26. PubMed ID: 4681258
[No Abstract] [Full Text] [Related]
8. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.
Phillips JK; Boyd R; Krockenberger MB; Burgio G
Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198
[TBL] [Abstract][Full Text] [Related]
9. [Studies on changes in serum creatinine concentration in polycystic kidney disease].
Shimizu T; Inaba S; Imai K; Yamanaka H; Kiren H; Kurihara H; Takahashi H; Makino T; Shibayama K
Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):97-102. PubMed ID: 3386015
[No Abstract] [Full Text] [Related]
10. Increased mean arterial pressure and aldosterone-to-renin ratio in Persian cats with polycystic kidney disease.
Pedersen KM; Pedersen HD; Häggström J; Koch J; Ersbøll AK
J Vet Intern Med; 2003; 17(1):21-7. PubMed ID: 12564723
[TBL] [Abstract][Full Text] [Related]
11. Age-Related Alterations in Blood Biochemical Characterization of Hepatorenal Function in the PCK Rat: A Model of Polycystic Kidney Disease.
Shimomura Y; Brock WJ; Ito Y; Morishita K
Int J Toxicol; 2015; 34(6):479-90. PubMed ID: 26503599
[TBL] [Abstract][Full Text] [Related]
12. Prognosis curves for patients with polycystic kidney disease.
Andersen S; Lindqvist B; Nyström L
Ann Clin Res; 1982 Apr; 14(2):90-2. PubMed ID: 6756272
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and pregnancy.
Jungers P; Forget D; Henry-Amar M; Albouze G; Fournier P; Vischer U; Droz D; Noël LH; Grunfeld JP
Adv Nephrol Necker Hosp; 1986; 15():103-41. PubMed ID: 3082109
[No Abstract] [Full Text] [Related]
14. Natriuresis-pressure relationship in polycystic kidney disease.
Schmid M; Mann JF; Stein G; Herter M; Nussberger J; Klingbeil A; Ritz E
J Hypertens; 1990 Mar; 8(3):277-83. PubMed ID: 2159509
[TBL] [Abstract][Full Text] [Related]
15. [Polycystic kidney disease in a patient using lithium chronically].
Atagün MI; Oral ET; Sevinç C
Turk Psikiyatri Derg; 2013; 24(3):213-6. PubMed ID: 24049011
[TBL] [Abstract][Full Text] [Related]
16. Thiamphenicol excretion in subjects with renal insufficiency.
Azzollini F; Gazzaniga A; Lodola E
Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):303-8. PubMed ID: 5494879
[No Abstract] [Full Text] [Related]
17. Thiamphenicol excretion in subjects with renal insufficiency.
Azzollini F; Gazzaniga A; Lodola E
Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):303-8. PubMed ID: 5481994
[No Abstract] [Full Text] [Related]
18. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Chapman AB; Johnson A; Gabow PA; Schrier RW
N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
[TBL] [Abstract][Full Text] [Related]
19. [Clinical aspects of polycystic disease of the kidney in the adult].
Aniceto J; Milhomens C; da Costa AG; Barbas JM; Correia AM; Pinto JL; de Almeida OM; Prata MM
Acta Med Port; 1985; 6(9-12):243-7. PubMed ID: 3832814
[No Abstract] [Full Text] [Related]
20. [Deviations in cholesterol metabolism as a risk factor in patients with chronic glomerulonephritis and with polycystic kidney].
Stríbrná J; Dobiásová M; Prát V; Matousovic K; Skibová J
Vnitr Lek; 1985 Mar; 31(3):285-91. PubMed ID: 4036017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
